Agfa-Gevaert Group is consolidating its x-ray film production facilities. The plan involves bringing all related U.S. x-ray film production activity to the company's Bushy Park, SC, facility and closing down
Agfa-Gevaert Group is consolidating its x-ray film production facilities. The plan involves bringing all related U.S. x-ray film production activity to the company's Bushy Park, SC, facility and closing down operations at its Brevard, NC, manufacturing facility by year's end. The action reflects a market shift from medical screen-film to dry hard-copy media and the need to realize worldwide manufacturing efficiencies. It also reflects the company's transition to more environmentally friendly products, according to Robert S. Pryor, president of Agfa HealthCare, Americas. The Brevard facility manufactures aqueous-coated medical x-ray film. North American product demand is shifting from that product to solvent-coated hard-copy media, Pryor said. To keep the Brevard facility in tune with North American customer demands, the company would have to invest in solvent-coating capability, which Pryor described as "financially unattractive." Instead, the company can structure operations in Bushy Park to support North American customers' demand for high-quality diagnostic x-ray film, along with other film and media products. The consolidation is part of a larger, global efficiency initiative that began last year. Facilities in Germany, Belgium, Spain, and the U.K. have also been affected.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.